Patent · US Active

Methods for measuring and improving CRISPR reagent function

US11078483B1 · kind B1 · utility

2Cited by
23References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 1, 2017
Grant dateAug 3, 2021
Priority date
Expiry dateMar 10, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16B35/10
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention describes a novel system for identifying optimized gRNAs for use in CRISPR/Cas9 genome editing platforms. The invention allows for the determination of specific gene alterations rendered by a particular gRNA, thereby permitting the generation of optimized gRNA libraries.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.